c-LEcta GmbH
Elena Kempf is a skilled biopharma professional currently serving as the Biopharma Innovation Manager at c-LEcta GmbH since February 2022, following a role as a Business Development Associate. Prior experience includes a position as a Scientist and Doctoral Student at Universität Leipzig from October 2015 to July 2021, as well as a Guest Scientist role at Joslin Diabetes Center in 2016. Elena holds a Doctorate in Biology from Leipzig University, a Master of Science in Molecular Medicine from Friedrich Schiller University Jena, and a Bachelor of Science in Biology from the same institution. Additionally, Elena has gained international experience as a Guest PhD Student at Harvard Medical School and as an ERASMUS student at Université Victor Segalen Bordeaux 2.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.